Nephros Operating Cycle from 2010 to 2026
| NEPH Stock | USD 3.87 0.01 0.26% |
Operating Cycle | First Reported 2010-12-31 | Previous Quarter 254.6 | Current Value 404.97 | Quarterly Volatility 335.08825308 |
Check Nephros financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Nephros' main balance sheet or income statement drivers, such as Depreciation And Amortization of 117.1 K, Interest Expense of 855 or Total Revenue of 17.1 M, as well as many indicators such as Price To Sales Ratio of 1.19, Dividend Yield of 0.0144 or PTB Ratio of 1.54. Nephros financial statements analysis is a perfect complement when working with Nephros Valuation or Volatility modules.
Nephros | Operating Cycle | Build AI portfolio with Nephros Stock |
The Operating Cycle trend for Nephros offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Nephros is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest Nephros' Operating Cycle Growth Pattern
Below is the plot of the Operating Cycle of Nephros over the last few years. It is Nephros' Operating Cycle historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Nephros' overall financial position and show how it may be relating to other accounts over time.
| Operating Cycle | 10 Years Trend |
|
Operating Cycle |
| Timeline |
Nephros Operating Cycle Regression Statistics
| Arithmetic Mean | 364.40 | |
| Geometric Mean | 294.50 | |
| Coefficient Of Variation | 91.96 | |
| Mean Deviation | 181.05 | |
| Median | 264.89 | |
| Standard Deviation | 335.09 | |
| Sample Variance | 112,284 | |
| Range | 1.5K | |
| R-Value | (0.30) | |
| Mean Square Error | 108,762 | |
| R-Squared | 0.09 | |
| Significance | 0.24 | |
| Slope | (20.12) | |
| Total Sum of Squares | 1.8M |
Nephros Operating Cycle History
About Nephros Financial Statements
Investors use fundamental indicators, such as Nephros' Operating Cycle, to determine how well the company is positioned to perform in the future. Although Nephros' investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
| Last Reported | Projected for Next Year | ||
| Operating Cycle | 254.60 | 404.97 |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out the analysis of Nephros Correlation against competitors. For more detail on how to invest in Nephros Stock please use our How to Invest in Nephros guide.You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Is there potential for Household Appliances market expansion? Will Nephros introduce new products? Factors like these will boost the valuation of Nephros. Anticipated expansion of Nephros directly elevates investor willingness to pay premium valuations. Understanding fair value requires weighing current performance against future potential. All the valuation information about Nephros listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.729 | Earnings Share 0.13 | Revenue Per Share | Quarterly Revenue Growth 0.354 | Return On Assets |
The market value of Nephros is measured differently than its book value, which is the value of Nephros that is recorded on the company's balance sheet. Investors also form their own opinion of Nephros' value that differs from its market value or its book value, called intrinsic value, which is Nephros' true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Nephros' market value can be influenced by many factors that don't directly affect Nephros' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Nephros' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Nephros should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Nephros' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.